PACT’s vision is to be the leader in creating, developing and commercializing cell-based therapies for the cure of cancer. Their mission is to leverage technology developed in the laboratories of Jim Heath and David Baltimore to advance the feasibility, affordability and clinical utilization of personalized neoantigen-specific adoptive cell therapy for cancer.
